| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/30/2002 | CN1333019A Injection for treating traumatic injury |
| 01/30/2002 | CN1333018A Medicine for treating immune relative disease of anterior chamber and surface of eye |
| 01/30/2002 | CN1333017A Application of rhein in treating insulin resistance |
| 01/30/2002 | CN1078614C Process for producing high-molecular-weight compounds of phenolic compounds etc, and use thereof |
| 01/30/2002 | CN1078469C Material for adjusting function of biology |
| 01/30/2002 | CN1078468C Use of chlorophyll copper sodium salt making composition for anti gastric mucosa damage |
| 01/30/2002 | CN1078467C Application of sinomenine in preparing analgesic |
| 01/30/2002 | CN1078466C New use of sinomenine |
| 01/30/2002 | CN1078465C Skin-penetrating absorption prepration containing ondansetron |
| 01/30/2002 | CN1078464C Medicinal composition for preventing and curing xerophthalmia and disease led themby, method and apparatus |
| 01/30/2002 | CN1078463C Ionene polymers and anthelmintics in animals |
| 01/30/2002 | CN1078462C Use of gossypol (and) its derivative as active component and use in preparation suppository in treating prostatitis |
| 01/30/2002 | CN1078461C Oestradiol transdermal therapeutic system comprising hydroscopic additives |
| 01/30/2002 | CN1078460C Program-controlled skin permeable plaster |
| 01/29/2002 | USRE37534 Pharmaceutical compositions |
| 01/29/2002 | US6343258 Method for testing for readiness for harvesting of tribulus terrestris l. having high steroidal saponin content |
| 01/29/2002 | US6342765 Imidazole derivatives and their use as farnesyl protein transferase inhibitors |
| 01/29/2002 | US6342604 Treating schizophrenia, depression, neuroses and psychoses which respond to dopamine d3 ligands |
| 01/29/2002 | US6342602 Bind specifically or selectively to rar-alpha receptors |
| 01/29/2002 | US6342601 Treating allograft rejection, rheumatoid arthritis |
| 01/29/2002 | US6342581 Genetic engineering and expression of polynucleotides and polypeptides; vectors, cells, antibodies for diagnosis and disease treatment |
| 01/29/2002 | US6342537 Gel for treatment of skin diseases and for disinfection of the skin |
| 01/29/2002 | US6342534 Analogs of biologically active, naturally occurring polyamines, pharmaceutical compositions and methods of treatment |
| 01/29/2002 | US6342533 Antidepressants udes for bipolar and attention deficit disorders, hyperactivity, parkinson's disease, epilepsy, eating disorders |
| 01/29/2002 | US6342532 Antiarthritic, hypotensive agents for urogenital and glandular disorders; calcium channels modulators |
| 01/29/2002 | US6342531 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 01/29/2002 | US6342530 Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt |
| 01/29/2002 | US6342529 GABA and L-glutamic acid analogs for antiseizure treatment |
| 01/29/2002 | US6342528 Control of microbial populations in the gastrointestinal tract of animals |
| 01/29/2002 | US6342526 Method for enhancing or achieving training-induced bradycardia with Carnitine |
| 01/29/2002 | US6342525 Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders |
| 01/29/2002 | US6342524 Use of non-steroidal anti-inflammatory agents in combination with compounds that have FP prostaglandin agonist activity to treat glaucoma and ocular hypertension |
| 01/29/2002 | US6342523 3,4,5-trisubstituted aryl nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation |
| 01/29/2002 | US6342521 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides |
| 01/29/2002 | US6342520 Locally injectable chemotherapeutics |
| 01/29/2002 | US6342519 Oxetanone compounds covelently linked with a polysacchride; lipase inhibitor |
| 01/29/2002 | US6342515 Remedy for neurodegenerative diseases |
| 01/29/2002 | US6342514 Administering an heterocycle with nitrogen for bone disorders |
| 01/29/2002 | US6342512 Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals |
| 01/29/2002 | US6342511 Racemic, enantiomorphs and diasteriomorphs |
| 01/29/2002 | US6342510 Antiinflammatory agents and enzyme inhibitors |
| 01/29/2002 | US6342509 Antiasthmatics, antihistamines or bronchodialators |
| 01/29/2002 | US6342508 N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/29/2002 | US6342506 Camptothesin derivatives for antitumor agents with nitro or amino derivatives possible |
| 01/29/2002 | US6342505 Use of 4-substituted tetrahydropyridines for making medicines acting on TGF-β1 |
| 01/29/2002 | US6342503 Antidepressants, eating disorders |
| 01/29/2002 | US6342502 Thieno[2,3-d]pyrimidine diones and their use in the treatment of reversible obstructive airways diseases |
| 01/29/2002 | US6342498 Arylpiperazines as serotonin reuptake inhibitors and 5-HT1Dα antagonists |
| 01/29/2002 | US6342497 2″-deoxy hygromycin derivatives |
| 01/29/2002 | US6342496 Bupropion metabolites and methods of use |
| 01/29/2002 | US6342494 Carbapenem compounds, use thereof, and intermediate compounds of the same |
| 01/29/2002 | US6342493 Crystallographically stable amorphous cephalosporin compositions and process for producing the same |
| 01/29/2002 | US6342492 Anti-viral triaza compounds and compositions |
| 01/29/2002 | US6342491 Method of treating estrogen receptor positive carcinoma with 17 α-dihydroequilin |
| 01/29/2002 | US6342490 Antiproliferation of cells |
| 01/29/2002 | US6342489 Treatment of iron deficiency with ferric salt of bis hemisuccinylursodeoxycholic acid |
| 01/29/2002 | US6342488 Treating psychosis without side effects in humans |
| 01/29/2002 | US6342487 Compositions containing at least one farnesyl transferase inhibitor and at least one topoisomerase inhibitor and compositions containing at least one farnesyl transferase inhibitor and at least one taxoid |
| 01/29/2002 | US6342486 Skin disorder treatment with glycans for antiinflammatory agents |
| 01/29/2002 | US6342485 Antitumor agents with nucleic acids |
| 01/29/2002 | US6342484 Method and compositions for promotion of wound treatment |
| 01/29/2002 | US6342482 Hair conditioners with spinosyn for killing lice |
| 01/29/2002 | US6342480 Tumor-activated prodrug compounds and treatment |
| 01/29/2002 | US6342476 Treating multiple sclerosis by administering a copolymer reacted with hydrobromic acid |
| 01/29/2002 | US6342392 Isolation of human and murine wild-type int6 gene cdna; cancer diagnosis; gene and immunotherapy; vaccines; gene expression |
| 01/29/2002 | US6342383 Reverse transcriptase activity; endogenous retroviruses |
| 01/29/2002 | US6342253 Use of essential oils to repel and treat head lice |
| 01/29/2002 | US6342251 Compositions for nasal administration |
| 01/29/2002 | US6342247 Pharmaceutical compositions containing irbesartan |
| 01/29/2002 | US6342246 Image forms and method for ameliorating male erectile dysfunction |
| 01/29/2002 | US6342245 Compositions of lipid lowering agents |
| 01/29/2002 | US6342244 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides, drugs and liposomes; upon cleavage of the linkage, the ligand |
| 01/29/2002 | US6342238 Organogel comprising an oxidation-sensitive hydrophilic compound, and uses thereof, in particular cosmetic uses |
| 01/29/2002 | US6342220 Agonist antibodies |
| 01/29/2002 | US6342215 Mutant microorganism having reduced adaptation to particular environment; avirulent pathogens for vaccines |
| 01/29/2002 | US6342213 Applying to surface of superficial non-suturable wound, in non-sterile environment, sufficient amount of cyanoacrylate adhesive to cover entire wound area, polymerizing adhesive to join separated skin sections and/or to form adhesive coating |
| 01/29/2002 | US6342202 Injecting into blood vessel composition consisting essentially of polyvinyl acetate having molecular weight of at least about 50,000, contrast agent and biocompatible solvent to precipitate polymer and embolize blood vessel |
| 01/29/2002 | US6341952 Fabrication of tissue products with additives by casting or molding using a mold formed by solid free-form methods |
| 01/29/2002 | CA2237780C Reduction of hair growth |
| 01/29/2002 | CA2229282C Use of hyaluronic acid as an immunosuppressant |
| 01/29/2002 | CA2223769C Method of treatment for asthma |
| 01/29/2002 | CA2216789C Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers |
| 01/29/2002 | CA2158575C Chlamydia vaccine and process |
| 01/29/2002 | CA2145296C Benzenealkanoic acids for cardiovascular diseases |
| 01/29/2002 | CA2107568C Use of sphingolipids in the preparation of a cosmetic or dermato-pharmaceutical composition for the protection of skin and hair against the harmful effects of atmospheric pollution |
| 01/29/2002 | CA2092330C Novel alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof |
| 01/29/2002 | CA2079328C Veterinary formulation of amoxycillin and clavulanic acid, and derivatives thereof |
| 01/29/2002 | CA2066374C Solution for perfusing primates |
| 01/29/2002 | CA2063127C Reduction in cutaneous atrophy |
| 01/29/2002 | CA2031368C Composition comprising non-steroidal non-inflammatory agent and effectively non-antibacterial tetracycline |
| 01/29/2002 | CA1341335C 9-amino-1, 4 ethano-1, 2, 3, 4-tetrahydroacridine and related compounds, intermediates and a process for the preparation thereof an their use as medicaments |
| 01/28/2002 | CA2704693A1 Indole derivatives and their use as medicaments |
| 01/28/2002 | CA2704691A1 Indole derivatives and their use as medicaments |
| 01/28/2002 | CA2354208A1 Compositions and methods for treating cataracts |
| 01/28/2002 | CA2354175A1 Process for the preparation of pyrazolo¬4,3-d|pyrimidin-7-one compounds and intermediates thereof |
| 01/28/2002 | CA2354110A1 Use of agonists of the prostaglandin ep 3 receptor as a cosmetic agent to mitigate, reduce or stop hair growth |
| 01/28/2002 | CA2354108A1 Use of agonists of the prostaglandin ep 3 receptor to mitigate, reduce or stop hair growth in cosmetic preparations |
| 01/28/2002 | CA2354107A1 Topical compounds including glucosyl hydroxystilbenes and uses |
| 01/28/2002 | CA2352645A1 Compositions for dna transfection |
| 01/27/2002 | CA2353768A1 Use of growth hormone secretagogues for improvement of functional health status |